Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer.

Journal of medical genetics - 1 Apr 2005

Vahteristo P, Ojala S, Tamminen A, Tommiska J, Sammalkorpi H, Kiuru-Kuhlefelt S, Eerola H, Aaltonen L A, Aittomäki K, Nevanlinna H

Abstract excerpt

BACKGROUND: The genetic background in breast cancer families with colorectal and/or endometrial cancer is mostly unknown. The functional connection between MSH6 and the known breast cancer predisposition gene product BRCA1 suggests that the MSH6 gene may also play a role in breast cancer predisposition. METHODS: We analysed 38 breast cancer families with colorectal and/or endometrial cancer for germline mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA-Binding Proteins

Share to Endometrial Neoplasms

Share to Family

Share to Finland

Share to Germ-Line Mutation

Share to Pedigree

Source

Open in PubMed Open full text

Identifiers

PMID: 15805151
DOI: 10.1136/jmg.2004.022327
PMCID: PMC1736038

Genes

MSH6
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer.PMID 15805151Read ↗

Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer.Semantic proximity Read ↗

Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.Semantic proximity Read ↗

Meta-analysis of MSH6 gene mutation frequency in colorectal and endometrial cancers.Semantic proximity Read ↗

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillanceSemantic proximity Read ↗

Cancer risks for<i>MSH6</i>pathogenic variant carriersSemantic proximity Read ↗

Familial endometrial cancer in female carriers of MSH6 germline mutationsSemantic proximity Read ↗

An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.Semantic proximity Read ↗

Risks of Lynch Syndrome Cancers for MSH6 Mutation CarriersSemantic proximity Read ↗

Characterisation of a Portuguese origin founder missense variant in MSH6Semantic proximity Read ↗

Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancerSemantic proximity Read ↗

Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.Semantic proximity Read ↗

A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case reportSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.